VYZULTA

This brand name is authorized in Brazil, Canada, Hong Kong, Turkey, United States

Active ingredients

The drug VYZULTA contains one active pharmaceutical ingredient (API):

1 Latanoprostene bunod
UNII I6393O0922 - LATANOPROSTENE BUNOD

Latanoprostene bunod is thought to lower intraocular pressure by increasing outflow of aqueous humor through both the trabecular meshwork and uveoscleral routes. Intraocular pressure is a major modifiable risk factor for glaucoma progression. Reduction of intraocular pressure reduces risk of glaucomatous visual field loss.

Read about Latanoprostene bunod

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
VYZULTA Οphthalmic solution FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01EE06 S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01EE Prostaglandin analogues
Discover more medicines within S01EE06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 503121080003002, 503121080003102
Country: CA Health Products and Food Branch Identifier(s): 02484218
Country: HK Department of Health Drug Office Identifier(s): 66408
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8681738610048
Country: US FDA, National Drug Code Identifier(s): 24208-504

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.